Prognostic value of 2-[18F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic value of 2-[18F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy

Published:2022-01 Issue: Volume:146 Page:110107
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Schweighofer-Zwink Gregor,Manafi-Farid Reyhaneh,Kölblinger Peter,Hehenwarter Lukas,Harsini Sara,Pirich Christian,Beheshti Mohsen

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference55 articles.

1. W.-Q.L. Natalie H. Matthews, Abrar A. Qureshi, Martin A. Weinstock, Eunyoung Cho, Epidemiology of Melanoma, in: W.H. Ward, J.M. Farma, Cutaneous Melanoma: Etiology and Therapy [Internet], Codon, Brisbane, Australia, 2017, pp. 3-22. https://doi.org/10.15586/codon.cutaneousmelanoma.2017.ch1.

2. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†;Michielin;Ann. Oncol.,2019

3. M.C.T. van Zeijl, L.C. de Wreede, A.J.M. van den Eertwegh, M. Wouters, A. Jochems, M.G. Schouwenburg, M.J.B. Aarts, A.C.J. van Akkooi, F. van den Berkmortel, J.W.B. de Groot, G.A.P. Hospers, E. Kapiteijn, D. Piersma, R.S. van Rijn, K.P.M. Suijkerbuijk, A.J. Ten Tije, A.A.M. van der Veldt, G. Vreugdenhil, J.J.M. van der Hoeven, J. Haanen, Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry, Eur. J. Cancer. 144 (2021) 242-251. https://doi.org/10.1016/j.ejca.2020.11.028.

4. Real-world outcomes of advanced melanoma patients not represented in phase III trials;van Zeijl;Int. J. Cancer.,2020

5. The advantages and challenges of using FDG PET/CT for response assessment in melanoma in the era of targeted agents and immunotherapy;Wong;Euro. J. Nucl. Med. Mol. Imaging,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel paradigm of therapeutic intervention for skin cancer: challenges and opportunities;Future Journal of Pharmaceutical Sciences;2024-09-02

2. Review on radiomic analysis in 18F-fluorodeoxyglucose positron emission tomography for prediction of melanoma outcomes;Cancer Imaging;2024-07-05

3. FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma;Clinical Cancer Research;2024-01-24

4. Can Baseline [¹⁸F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study;Cancer Biotherapy and Radiopharmaceuticals;2023-05-01

5. [18F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy;Diagnostics;2023-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3